Viral Hepatitis
Viral Hepatitis - Related Videos
01:28
Viral Hepatitis I: Introduction
0 Views •
2026
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
02:50
Suppressing Hepatitis B Virus Replication Using Viral Antigen-Specific T Cells
0 Views •
2025
The video demonstrates an assay using human induced pluripotent stem cell (iPSC)-derived CD8+ T cells to inhibit hepatitis B virus (HBV) replication in mice. These T cells, engineered with HBV-specific receptors, are transferred into transgenic mice. Replication-competent HBV genome plasmids are then injected directly into the liver, enabling viral DNA uptake. Once viral antigens are expressed and presented by hybrid MHC-I molecules, the engineered T cells recognize and bind to these complexes.
02:27
Measuring Hepatitis C Viral Load Using Quantitative Reverse Transcription Polymerase Chain Reaction
0 Views •
2026
Source: Ren, S., et al. A Protocol for Analyzing Hepatitis C Virus Replication. J. Vis. Exp. (2014).This video demonstrates the procedure for quantifying Hepatitis C viral RNA using quantitative reverse transcription PCR to measure viral load in infected cell cultures.
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
0 Views •
Cited by 2 •
2014
Hepatitis C Virus (HCV) is a major human pathogen that causes liver disorders, including cirrhosis and cancer. An HCV infectious cell culture system is essential for understanding the molecular mechanism of HCV replication and developing new therapeutic approaches. Here we describe a protocol to investigate various stages of the HCV replication cycle.
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
0 Views •
Cited by 3 •
2018
We describe here the in vitro generation of HBV DNA via a Hepatitis B virus infection system and the highly sensitive detection of its (1–2 copies) integration using inverse nested PCR.
FAQs
Once inside the body, hepatitis viruses target hepatocytes, the liver cells that support their replication. They redirect host-cell machinery to produce new viral material. This interaction is central to host-pathogen biology because viral multiplication and cellular responses occur together, helping explain how infection can progress from an initial encounter to broader liver inflammation and tissue injury.
The immune response is intended to control infection, yet it can also damage liver tissue as it reacts to infected hepatocytes. This dual effect illustrates a central host-pathogen principle: disease severity reflects not only viral replication but also the host response. Studying that interaction helps explain inflammation and the transition from infection to liver injury.
Acute infection describes an initial disease phase, whereas persistent infection continues over time and can produce progressive liver damage. In viral hepatitis, persistence is especially important because it may be associated with fibrosis, cirrhosis, or liver cancer. Comparing these courses helps biologists connect infection duration with different tissue outcomes and long-term health risks.
Diagnostic testing helps identify viral hepatitis and supports decisions about how an infection should be addressed. Antiviral treatment is one of the clinical strategies linked to this information, while ongoing study connects test results with the biology of viral replication and liver injury. Together, testing and treatment support efforts to limit disease and reduce long-term complications.
Vaccination and prevention strategies address viral hepatitis before infection produces liver injury or spreads further. Their importance follows from the disease’s transmission routes: reducing transmission lowers the number of new infections, while vaccination provides a specific preventive approach. In public health and biology, these measures connect knowledge of viral spread with population-level reduction of liver-related complications.
Research on viral hepatitis links molecular events in hepatocytes with outcomes that matter at the population level. Investigators can examine host-cell machinery, immune-mediated tissue damage, transmission routes, and progression toward fibrosis, cirrhosis, or liver cancer. This integrated perspective explains why the topic belongs to biology while also informing infectious-disease research and public-health strategies.